Literature DB >> 11147177

The protective role of atorvastatin on function, structure and ultrastructure in the aorta of dyslipidemic rabbits.

P Aragoncillo1, R Maeso, S Vázquez-Pérez, J Navarro-Cid, L M Ruilope, C Díaz, G Hernández, V Lahera, V Cachofeiro.   

Abstract

Responses to both an endothelium-dependent (acetylcholine 10(-9)-10(-5) mol/l) and an endothelium-independent vasodilator (sodium nitroprusside 10(-10)-10(-6) mol/l) were studied in aortic rings from rabbits fed or not with a diet containing 0.5% cholesterol plus 14% coconut oil for 14 weeks and treated or not with atorvastatin (2.5 mg/kg/day). Morphometric and ultrastructure analyses were also performed. Rabbits fed the dyslipidemic diet presented higher plasma cholesterol and triglyceride concentrations than controls (P < 0.05). This was associated with intima-media thickening and, consequently, aortic stenosis (29 +/- 3%) since vessel cross-sectional area did not change. Endothelial cells presented numerous alterations in dyslipidemic rabbits. Atorvastatin treatment only reduced plasma levels in dyslipidemic rabbits (P < 0.05), which were nevertheless higher than those of controls. In addition, it prevented the reduction in acetylcholine relaxation in hypercholesterolemic animals. Atorvastatin administration also enhanced the response to acetylcholine in rabbits fed a control diet. Likewise, atorvastatin treatment reduced lesion area and consequently increased aortic lumen in dyslipidemic rabbits but did not modify media thickening. It also prevented the majority of the ultrastructural changes observed in endothelial cells. In conclusion, chronic atorvastatin treatment exerts a protective role in vascular function, structure and ultrastructure even in the presence of high cholesterol and triglyceride plasma levels.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11147177     DOI: 10.1007/s004280000278

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  2 in total

Review 1.  Status and prospects of percutaneous vertebroplasty combined with ¹²⁵I seed implantation for the treatment of spinal metastases.

Authors:  Lin Xie; Yanjin Chen; Ya Zhang; Zuozhang Yang; Zhaoxin Zhang; Lida Shen; Zhongqin Yuan; Mingyan Ren
Journal:  World J Surg Oncol       Date:  2015-03-25       Impact factor: 2.754

2.  Inflammation but not endothelial dysfunction is associated with the severity of coronary artery disease in dyslipidemic subjects.

Authors:  Christian F Rueda-Clausen; Patricio López-Jaramillo; Carlos Luengas; Maria del Pilar Oubiña; Victoria Cachofeiro; Vicente Lahera
Journal:  Mediators Inflamm       Date:  2009-06-23       Impact factor: 4.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.